Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Wraith

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Human Mutation|January 1, 1997
Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS geneS Tomatsu, S Fukuda, A Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrowL J Fairbairn, L S Lashford, E Spooncer, et al.
Casopis Lekaru Ceskych|January 8, 1997
Towards gene therapy of Hurler syndromeL J Fairbairn, L S Lashford, E Spooncer, et al.
Journal of Inherited Metabolic Disease|June 7, 2012
Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapyE Braunlin, H Rosenfeld, C Kampmann, et al.
Neurology|December 8, 2006
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe diseaseP S Kishnani, D Corzo, M Nicolino, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Human Mutation|January 1, 1997
Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS geneS Tomatsu, S Fukuda, A Cooper, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 1996
Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrowL J Fairbairn, L S Lashford, E Spooncer, et al.
Casopis Lekaru Ceskych|January 8, 1997
Towards gene therapy of Hurler syndromeL J Fairbairn, L S Lashford, E Spooncer, et al.
Journal of Inherited Metabolic Disease|June 7, 2012
Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapyE Braunlin, H Rosenfeld, C Kampmann, et al.
Neurology|December 8, 2006
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe diseaseP S Kishnani, D Corzo, M Nicolino, et al.
Pageof 12